Progress in Mind Go to Progress in Mind Main channel featuring interviews, articles, congress highlights and much more. Go to channel
Lundbeck Institute Campus. Go to Lundbeck Institute Campus. Medical education resource center in psychiatry and neurology. Go to channel
Alzheimer's Disease, Parkinson's Disease Congress highlights A pick of the mix Though EAN 2020 was virtual, the variety and quality of its presentations was very real. These are... Content action menuShareTestTest 2Test 3
Parkinson's Disease Congress highlights Is mild cognitive impairment in Parkinson’s disease a useful diagnosis? The question is one of neurology’s many enduring and intriguing debates. At the AAT-AD/PD... Content action menuShareTestTest 2Test 3
Schizophrenia Article The neurobiology of conversion to psychosis – emerging findings from the SHARP study The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to... Content action menuShareTestTest 2Test 3
Schizophrenia Congress highlights Early intervention for psychosis: Is it worth the investment? In a session at WFSBP, chaired by Professor Matcheri Keshavan, Harvard Medical School, Boston, MA,... Content action menuShareTestTest 2Test 3
Bipolar Satellite symposium Maintaining functioning in bipolar disorder: Treat early and prevent relapses Bipolar disorder (BD) should be considered a neuroprogressive disorder with poor outcomes1 said... Content action menuShareTestTest 2Test 3
Schizophrenia Article Will the reconceptualization of negative symptoms lead to an effective therapy? A recent reconceptualization of the negative symptoms of schizophrenia promises to increase... Content action menuShareTestTest 2Test 3
Schizophrenia Article Biomarkers - the Future of Diagnosis in Psychiatry? Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope... Content action menuShareTestTest 2Test 3
Schizophrenia Article Refining and redefining diagnosis and prognosis in psychosis: can biomarkers and imaging help? Consortia the world over are seeking biomarkers, including abnormalities on brain imaging, that... Content action menuShareTestTest 2Test 3
Depression, Schizophrenia Article ICD-11: new and fit for clinical utility and consistency The new ICD chapter on mental health and behavioral disorders is designed to offer guidelines to... Content action menuShareTestTest 2Test 3
Mental health Article Train, test, predict: Using big data and machine learning in psychiatry Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine... Content action menuShareTestTest 2Test 3
Schizophrenia Article Future of schizophrenia treatment: Where do we go now? Over the next decade, the outcomes for patients with schizophrenia should improve considerably,... Content action menuShareTestTest 2Test 3
Depression Congress highlights Severity and Treatment of Depression: A Review of Two Controversies Antidepressants are not limited to severely depressed patients, and psychotherapy is not limited to... Content action menuShareTestTest 2Test 3